{"name":"KYMAB LIMITED","company_number":"07027523","status":"Active","type":"Private Limited Company","incorporated":"2009-09-23","dissolved":null,"registered_office":"The Eddeva Building (B920), Babraham Research Campus, Cambridge, England, CB22 3AT","postcode":"CB22 3AT","sic_codes":[{"code":74909,"description":"Other professional, scientific and technical activities not elsewhere classified"}],"principal_activity":null,"previous_names":[],"warnings":[],"accounts":{"category":"Full","year_end":"31 December","last_made_up_to":"2025-12-31","next_due":"2027-09-30"},"employees":null,"financials":[],"officers":{"current":5,"resigned":19,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":0,"outstanding":0},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"KYMAB LIMITED operates within the highly capital-intensive UK biotechnology sector, leveraging its proprietary Kymouse platform to maintain a strong competitive position in antibody therapeutics. While typical biotechs face severe cash burn and funding cliffs, Kymab's integration into a larger pharmaceutical group structure provides significant financial stability, allowing it to outperform many standalone peers within the Cambridge innovation cluster.","website":"https://www.kymab.com/","links":{"page":"https://www.companiesintheuk.co.uk/ltd/kymab","people":"https://www.companiesintheuk.co.uk/company/kymab/people","filing_history":"https://www.companiesintheuk.co.uk/company/kymab/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/07027523","control":"https://www.companiesintheuk.co.uk/company/kymab/control","ai_analysis":"https://www.companiesintheuk.co.uk/company/kymab/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/kymab"}